Chapter 74 – Renal Failure in Adults

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/B978-1-4557-0268-8.00074-9
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Hepatorenal Syndrome in the Intensive Care Unit

  2013cited by this paper
• Futility and rationing in liver retransplantation: when and how can we say no?

  2012cited by this paper
• Sirolimus Conversion Regimen Versus Continued Calcineurin Inhibitors in Liver Allograft Recipients: A Randomized Trial

  2012cited by this paper
• Impact of the etiology of acute kidney injury on outcomes following liver transplantation: acute tubular necrosis versus hepatorenal syndrome

  2012cited by this paper
• Impact of liver transplantation on the survival of patients treated for hepatorenal syndrome type 1 *

  2011cited by this paper
• Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics.

  2011cited by this paper
• Tolerability of everolimus‐based immunosuppression in maintenance liver transplant recipients

  2011cited by this paper
• Therapeutic response to vasoconstrictors in hepatorenal syndrome parallels increase in mean arterial pressure: a pooled analysis of clinical trials.

  2011cited by this paper
• Postliver Transplant Acute Renal Injury and Failure by the RIFLE Criteria in Patients With Normal Pretransplant Serum Creatinine Concentrations: A Matched Study

  2011cited by this paper
• Hepatorenal syndrome, pharmacological therapy, and liver transplantation

  2011cited by this paper
• Calcineurin-Inhibitor Minimization in Liver Transplant Patients with Calcineurin-Inhibitor-Related Renal Dysfunction: A Meta-Analysis

  2011cited by this paper
• Liver Transplant Outcomes for Patients With Hepatorenal Syndrome Treated With Pretransplant Vasoconstrictors and Albumin

  2011cited by this paper
• Does hepatorenal syndrome affect the result of liver transplantation? Clinical observations.

  2010cited by this paper
• Hyponatremia

  2010cited by this paper
• Terlipressin therapy for renal failure in cirrhosis

  2010cited by this paper
• Interaction Between Everolimus and Tacrolimus in Renal Transplant Recipients: A Pharmacokinetic Controlled Trial

  2010cited by this paper
• Transplantation Outcomes in Primary Hyperoxaluria

  2010cited by this paper
• Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis

  2010cited by this paper
• Medical and surgical treatment options for polycystic liver disease 1

  2010cited by this paper
• Comparison of surgical methods in liver transplantation: retrohepatic caval resection with venovenous bypass (VVB) versus piggyback (PB) with VVB versus PB without VVB

  2010cited by this paper
• Indications for combined liver and kidney transplantation: propositions after a 23‐yr experience

  2010cited by this paper
• Pentoxifylline for alcoholic hepatitis.

  2009cited by this paper
• Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment

  2009cited by this paper
• The primary hyperoxalurias.

  2009cited by this paper
• Proceedings of Consensus Conference on Simultaneous Liver Kidney Transplantation (SLK)

  2008cited by this paper
• Analysis of Kidney Function and Biopsy Results in Liver Failure Patients With Renal Dysfunction: A New Look to Combined Liver Kidney Allocation in the Post-MELD Era

  2008cited by this paper
• Donor biopsy and kidney transplant outcomes: an analysis using the Organ Procurement and Transplantation Network/United Network for Organ Sharing (OPTN/UNOS) database: Bajwa M, Cho YW, Pham PT, et al (Univ of California, Los Angeles) Transplantation 84:1399-1405, 2007 §

  2008cited by this paper
• A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome.

  2008cited by this paper
• Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study.

  2008cited by this paper
• Conversion to sirolimus‐based immunosuppression in maintenance liver transplantation patients

  2007cited by this paper
• Renal function outcomes following liver transplantation and combined liver–kidney transplantation

  2007cited by this paper
• Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis

  2007cited by this paper
• Octreotide/Midodrine Therapy Significantly Improves Renal Function and 30-Day Survival in Patients with Type 1 Hepatorenal Syndrome

  2007cited by this paper
• Hepatorenal syndrome: A proposal for kidney after liver transplantation (KALT)

  2007cited by this paper
• Conversion to sirolimus for chronic allograft dysfunction: long‐term results confirm predictive value of proteinuria

  2007cited by this paper
• The course of type 1 hepato-renal syndrome post liver transplantation.

  2006cited by this paper
• 12‐month follow‐up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus

  2006cited by this paper
• Differential pharmacokinetic interaction of tacrolimus and cyclosporine on everolimus.

  2006cited by this paper
• A 20-Year Experience of Combined Liver/Kidney Transplantation for Primary Hyperoxaluria (PH1): The European PH1 Transplant Registry Experience 1984–2004

  2005cited by this paper
• American Association for the Study of Liver Diseases Practice Guidelines: the role of transjugular intrahepatic portosystemic shunt creation in the management of portal hypertension.

  2005cited by this paper
• Frequency of hepatorenal syndrome among cirrhotics.

  2005cited by this paper
• Hyponatremia in liver cirrhosis: pathophysiological principles of management.

  2005cited by this paper
• Chapter 36 – Diagnosis and Therapy of Graft Dysfunction

  2005cited by this paper
• The Effects of Chronic Treatment with Octreotide versus Octreotide plus Midodrine on Systemic Hemodynamics and Renal Hemodynamics and Function in Nonazotemic Cirrhotic Patients with Ascites

  2005cited by this paper
• Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome

  2004cited by this paper
• Estimation of glomerular filtration rates before and after orthotopic liver transplantation: Evaluation of current equations

  2004cited by this paper
• EFFICACY OF MYCOPHENOLATE MOFETIL COMBINED WITH VERY LOW‐DOSE CYCLOSPORINE MICROEMULSION IN LONG‐TERM LIVER‐TRANSPLANT PATIENTS WITH RENAL DYSFUNCTION

  2003cited by this paper
• Switching cyclosporine blood concentration monitoring from C0 to C2 in children late after liver transplantation.

  2003cited by this paper
• Risk Factors for Development of Acute Renal Failure After Liver Transplantation

  2003cited by this paper
• Chronic renal failure after transplantation of a nonrenal organ.

  2003cited by this paper
• Pharmacokinetics of tacrolimus-based combination therapies.

  2003cited by this paper
• Independent risk factors and natural history of renal dysfunction in liver transplant recipients

  2003cited by this paper
• Severe acute renal failure after exposure to sirolimus-tacrolimus in two livin donor kidney reciplents

  2003cited by this paper
• Octreotide in hepatorenal syndrome: A randomized, double‐blind, placebo‐controlled, crossover study

  2003cited by this paper
• Sirolimus monotherapy in nephrotoxicity due to calcineurin inhibitors in liver transplant recipients

  2003cited by this paper
• Effect of celecoxib on renal function in cirrhotic patients with ascites. A pilot study

  2002cited by this paper
• Identification of patients best suited for combined liver–kidney transplantation: Part II

  2002cited by this paper
• Evaluation of acute renal failure in the liver transplantation perioperative period: incidence and impact.

  2002cited by this paper
• Renal failure in cirrhotic patients: role of terlipressin in clinical approach to hepatorenal syndrome type 2

  2002cited by this paper
• Anti-CD25 monoclonal antibody coverage allows for calcineurin inhibitor “holiday” in solid organ transplant patients with acute renal dysfunction1

  2002cited by this paper
• Clinical use of c2 monitoring in long-term liver transplant recipients.

  2002cited by this paper
• Predictors of late kidney dysfunction post-liver transplantation.

  2002cited by this paper
• Pathophysiology of renal disease associated with liver disorders: Implications for liver transplantation. Part I

  2002cited by this paper
• Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: Results of a prospective, nonrandomized study

  2002cited by this paper
• Effect of terlipressin (Glypressin®) on hepatorenal syndrome in cirrhotic patients: results of a multicentre pilot study*

  2002cited by this paper
• Renal failure after liver transplantation: outcome after calcineurin inhibitor withdrawal

  2002cited by this paper
• Albumin dialysis in cirrhosis with superimposed acute liver injury: A prospective, controlled study

  2002cited by this paper
• Transjugular renal biopsy in patients with liver disease.

  2001cited by this paper
• End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of development and treatment.

  2001cited by this paper
• Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis

  2001cited by this paper
• Pharmacokinetic interactions augment toxicities of sirolimus/cyclosporine combinations.

  2001cited by this paper
• Long-term terlipressin administration improves renal function in cirrhotic patients with type 1 hepatorenal syndrome: a pilot study.

  2001cited by this paper
• A WORLDWIDE, PHASE III, RANDOMIZED, CONTROLLED, SAFETY AND EFFICACY STUDY OF A SIROLIMUS/CYCLOSPORINE REGIMEN FOR PREVENTION OF ACUTE REJECTION IN RECIPIENTS OF PRIMARY MISMATCHED RENAL ALLOGRAFTS

  2001cited by this paper
• Renal replacement therapy and orthotopic liver transplantation: the role of continuous veno-venous hemodialysis.

  2001cited by this paper
• Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study

  2000cited by this paper
• Late-onset renal failure after liver transplantation: role of posttransplant alcohol use.

  2000cited by this paper
• The kidney in liver transplantation.

  2000cited by this paper
• Improvement of hepatorenal syndrome with extracorporeal albumin dialysis mars: Results of a prospective, randomized, controlled clinical trial

  2000cited by this paper
• Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

  2000cited by this paper
• Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome.

  2000cited by this paper
• What is new in primary hyperoxaluria?

  1999cited by this paper
• [Fluid and electrolyte disorders]

  1999cited by this paper
• Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.

  1999cited by this paper
• Combined liver-kidney transplantation in primary hyperoxaluria type 1

  1999cited by this paper
• Long‐term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine

  1999cited by this paper
• Is there a role for continuous renal replacement therapies in patients with liver and renal failure?

  1999cited by this paper
• Transplantation for primary hyperoxaluria in the United States.

  1999cited by this paper
• The results of combined liver/kidney transplantation for primary hyperoxaluria (PH1) 1984-1997. The European PH1 transplant registry report. European PH1 Transplantation Study Group.

  1998cited by this paper
• Beneficial effects of the 2‐day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome

  1998cited by this paper
• Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: Effects on renal function and vasoactive systems

  1998cited by this paper
• Impact of acute renal failure on mortality in end-stage liver disease with or without transplantation.

  1998cited by this paper
• Comparison of neoral dose monitoring with cyclosporine through levels versus 2-hr postdose levels in stable liver transplant patients.

  1998cited by this paper
• Chronic renal failure following liver transplantation: a retrospective analysis.

  1998cited by this paper
• The hyperventilation of cirrhosis: Progesterone and estradiol effects

  1997cited by this paper
• Ionized hypomagnesemia in patients undergoing orthotopic liver transplantation: a complication of citrate intoxication.

  1996cited by this paper
• Effect of venovenous bypass on perioperative renal function in liver transplantation: Results of a randomized, controlled trial

  1996cited by this paper
• Amelioration of hepatorenal syndrome with selective endothelin-A antagonist.

  1996cited by this paper
• Study of arterial blood gases in liver cirrhosis with and without ascites

  1996cited by this paper
• Central pontine myelinolysis with stupor alone after orthotopic liver transplantation.

  1996cited by this paper
• Transjugular renal biopsy in the treatment of patients with cirrhosis and renal abnormalities

  1996cited by this paper

• Critical Care of the Liver Transplant Recipient

  2015cites this paper